{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:06:51Z","timestamp":1789056411887,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201788","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:06:02Z","timestamp":1781712362000},"page":"201788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial transplantation reverses the senescence phenotype of SH-SY5Y cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Liqun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingnan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1551-5931","authenticated-orcid":false,"given":"Chi-ju","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201788_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells14040276","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"14","author":"Yang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201788_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201788_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.omta.2026.201788_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omta.2026.201788_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201788_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omta.2026.201788_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omta.2026.201788_bib8","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201788_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nbd.2014.06.017","article-title":"Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein","volume":"70","author":"Subramaniam","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2026.201788_bib10","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","article-title":"Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production","volume":"74","author":"Tapias","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omta.2026.201788_bib11","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.1523\/JNEUROSCI.1659-16.2016","article-title":"Monomeric alpha-Synuclein exerts a physiological role on brain ATP synthase","volume":"36","author":"Ludtmann","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omta.2026.201788_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omta.2026.201788_bib13","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1074\/jbc.M109.061051","article-title":"The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition","volume":"285","author":"Loeb","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201788_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.166","article-title":"Aggregated alpha-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons","volume":"6","author":"Reeve","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omta.2026.201788_bib15","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1002\/mds.22781","article-title":"Mitochondrial therapies for Parkinson's disease","volume":"25","author":"Thomas","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.omta.2026.201788_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omta.2026.201788_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2174\/1871527322666230330122444","article-title":"Clinical benefits of therapeutic interventions targeting mitochondria in Parkinson's disease patients","volume":"23","author":"Ciocca","year":"2024","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.omta.2026.201788_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.970925","article-title":"The neuroprotective efects of glucagon-like peptide 1 in Alzheimer\u2019s and Parkinson\u2019s disease: an in-depth review","volume":"16","author":"Reich","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omta.2026.201788_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","article-title":"PPARgamma and PGC-1alpha as therapeutic targets in Parkinson\u2019s","volume":"40","author":"Corona","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.omta.2026.201788_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-016-0090-7","article-title":"Pioglitazone ameliorates the phenotype of a novel Parkinson\u2019s disease mouse model by reducing neuroinfammation","volume":"11","author":"Pinto","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omta.2026.201788_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114268","article-title":"Inter and intracellular mitochondrial transfer: Future of mitochondrial transplant therapy in Parkinson's disease","volume":"159","author":"Jain","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omta.2026.201788_bib22","first-page":"147","article-title":"Potential applications of mitochondrial therapy with a focus on Parkinson's disease and mitochondrial transplantation","volume":"14","author":"Wal","year":"2023","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.omta.2026.201788_bib23","article-title":"Intranasal delivery of mitochondria for treatment of Parkinson's Disease model rats lesioned with 6-hydroxydopamine","volume":"11","author":"Chang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201788_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00355","article-title":"Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson's disease","volume":"21","author":"Eo","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omta.2026.201788_bib25","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1172\/JCI124944","article-title":"Mitochondrial transplantation in humans: \u201cmagical\u201d cure or cause for concern?","volume":"128","author":"Bertero","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201788_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050964","article-title":"Mitochondrial transplantation-a possible therapeutic for mitochondrial dysfunction?: Mitochondrial transfer is a potential cure for many diseases but proof of efficacy and safety is still lacking","volume":"21","author":"Lightowlers","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omta.2026.201788_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10544-016-0066-y","article-title":"Incorporation of VSV-G produces fusogenic plasma membrane vesicles capable of efficient transfer of bioactive macromolecules and mitochondria","volume":"18","author":"Lin","year":"2016","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.omta.2026.201788_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13287-020-01738-z","article-title":"Plasma membrane vesicles of human umbilical cord mesenchymal stem cells ameliorate acetaminophen-induced damage in HepG2 cells: a novel stem cell therapy","volume":"11","author":"Lin","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omta.2026.201788_bib29","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/cells10071694","article-title":"Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson's disease models","volume":"10","author":"Verma","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201788_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41401-023-01153-z","article-title":"Cell senescence induced by toxic interaction between \u03b1-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease","volume":"45","author":"Shen","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.omta.2026.201788_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1877718X251316552","article-title":"Aging, cellular senescence and Parkinson's disease","volume":"15","author":"Ma","year":"2025","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.omta.2026.201788_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mehy.2012.05.008","article-title":"L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients","volume":"79","author":"Borah","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.omta.2026.201788_bib33","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s12276-025-01480-7","article-title":"Hallmarks of cellular senescence: biology, mechanisms, regulations","volume":"57","author":"Ajoolabady","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omta.2026.201788_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13316","article-title":"Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells","volume":"20","author":"Zhou","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.omta.2026.201788_bib35","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1016\/S0021-9258(19)42620-3","article-title":"Rhodamine 6G. A potent inhibitor of mitochondrial oxidative phosphorylation","volume":"249","author":"Gear","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201788_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbrc.2004.08.177","article-title":"Cardiolipin induces premature senescence in normal human fibroblasts","volume":"323","author":"Arivazhagan","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omta.2026.201788_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson's disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omta.2026.201788_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/jbcpp-2019-0270","article-title":"6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels","volume":"32","author":"Elyasi","year":"2020","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.omta.2026.201788_bib39","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1126\/science.adi3450","article-title":"Neuronal senescence may drive brain aging","volume":"384","author":"Herdy","year":"2024","journal-title":"Science."},{"key":"10.1016\/j.omta.2026.201788_bib40","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.18632\/aging.206030","article-title":"Lipid accumulation drives cellular senescence in dopaminergic neurons","volume":"16","author":"Russo","year":"2024","journal-title":"Aging"},{"key":"10.1016\/j.omta.2026.201788_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.stem.2019.08.013","article-title":"Loss of SATB1 iInduces p21-dependent cellular senescence in post-mitotic dopaminergic neurons","volume":"25","author":"Riessland","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201788_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105971","article-title":"Mitochondrial transplantation in brain disorders: Achievements, methods, and challenges","volume":"169","author":"Riou","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.omta.2026.201788_bib43","doi-asserted-by":"crossref","first-page":"H94","DOI":"10.1152\/ajpheart.00567.2008","article-title":"Injection of isolated mitochondria during early reperfusion for cardioprotection","volume":"296","author":"McCully","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.omta.2026.201788_bib44","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1073\/pnas.1513047112","article-title":"Mitochondrial calcium overload is a key determinant in heart failure","volume":"112","author":"Santulli","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omta.2026.201788_bib45","doi-asserted-by":"crossref","DOI":"10.3724\/abbs.2026031","article-title":"Fabrication of fusogenic and magnet-responsive cells for transplantation of an intact mitochondrial network","author":"Xu","year":"2026","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.omta.2026.201788_bib46","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1038\/s41467-025-64147-x","article-title":"Quantitative cellular characterization of extracellular mitochondria uptake and delivery","volume":"16","author":"Al Amir Dache","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201788_bib47","article-title":"Inhibition and rescue of hyperglycemia-induced cellular senescence by mitochondrial transfer from enucleated mesenchymal stem cell-derived microvesicles for chronic wound healing","volume":"12","author":"Dong","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.omta.2026.201788_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41418-020-0601-5","article-title":"Pyrroline-5-carboxylate synthase senses cellular stress and modulates metabolism by regulating mitochondrial respiration","volume":"28","author":"Yang","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omta.2026.201788_bib49","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41586-024-08146-w","article-title":"Cellular ATP demand creates metabolically distinct subpopulations of mitochondria","volume":"635","author":"Ryu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201788_bib50","article-title":"Stereotaxic intracranial delivery of chemicals, proteins or viral vectors to study Parkinson's disease","volume":"168","author":"Landeck","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omta.2026.201788_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/1471-2105-7-379","article-title":"V-MitoSNP: visualization of human mitochondrial SNPs","volume":"7","author":"Chuang","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omta.2026.201788_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2009.01.016","article-title":"High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish","volume":"200","author":"Chatterjee","year":"2009","journal-title":"Behav. Brain Res."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:13:34Z","timestamp":1789053214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001230"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201788","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial transplantation reverses the senescence phenotype of SH-SY5Y cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Shantou University. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201788"}}